This panel includes blood and urine tests commonly used by physicians to determine kidney dysfunction: Urinalysis, Comprehensive Metabolic Panel (CMP), Cystatin C and eGFR.

Protein, Gloublin and Albumin - The major proteins seen in the serum are albumin and globulin-the latter being primarily alpha 1 and alpha 2 globulin, beta globulin and gamma globulin. Albumin accounts for more than 50% of the total serum proteins. The albumin to globulin (A/G) ratio has been used as an index of disease state, however, it is not a specific marker for disease because it does not indicate which specific proteins are altered. The normal A/G ratio is 0.8-2.0. The A/G ratio can be decreased in response to a low albumin or to elevated globulins. Total globulins may be increased in some chronic inflammatory diseases (TB, syphilis) multiple myeloma, collagen disease, and rheumatoid arthritis.  Decreased levels are seen in hepatic dysfunction, renal disease and various neoplasms.

This panel is the most inclusive of all offered on the site for men who want a wide picture of their health or who are considering starting testosterone replacement therapy.  It provides a baseline overview of your sex hormones, thyroid gland, adrenal function, metabolic function, cholesterol, prostate, and overall health.  Tests included: 

• CBC
• CMP
• Lipid Panel
• Testosterone
• Total (LC/MS) Estradiol, Ultra Sensitive
• DHEA-s
• TSH
• Free T3
• PSA
• LH
• FSH

The adrenal gland produces a hormone known as dehydroepiandrosterone (DHEA). It is also made in the brain. DHEA leads to the production of androgens and estrogens (male and female sex hormones). DHEA levels in the body begin to decrease after age 30. Lower DHEA levels are found in people with hormonal disorders, HIV/AIDS, Alzheimer's disease, heart disease, depression, diabetes, inflammation, immune disorders, and osteoporosis. Corticosteroids, birth control taken by mouth, and agents that treat psychiatric disorders may reduce DHEA levels.

This test measures the free (unbound to SHBG or albumin) estradiol and total sensitive estradiol in blood. The test is performed using liquid chromatography/mass spectrometry (LC/MS). NOTE: This test is a send out test to Quest's Nichols Institute San Juan Capistrano.  Testing schedule is Mon and Wed.  Reports are available within 4-14 days from the time the specimen is received at the send out testing lab. Test results may take up to 16 business days.

This panel measures the blood levels of arsenic, lead, and mercury.

ApoB Blood Test has been reported to be a powerful indicator of Coronary Artery Disease (CAD). In some patients with CAD, APO B is elevated even in the presence of normal LDL cholesterol. Instead of non-HDL-C levels, ApoB levels may be used to check how well lipid treatment is working. Non-HDL-C is the total cholesterol concentration minus the amount of HDL. A healthcare practitioner may order both an lipoprotein a (associated with high-density lipoprotein (HDL), the "good" cholesterol) and an apo B to determine an apo B/apo A-I ratio. This ratio is sometimes used as an alternative to a total cholesterol/HDL ratio to evaluate risk for developing CVD.

This high sensitivity CRP test is used along other blood markers to assess a patient's potential risk for cardiovascular disease. To illustrate the difference between CRP and hs-CRP, traditional testing measures CRP (quantitative) within the range of 10 to 1,000 mg/L, whereas hs-CRP values range from 0.5 to 10 mg/L. In simpler terms, hs-CRP measures trace amounts of CRP in the blood. Hs-CRP is the analyte of choice for cardiovascular risk assessment

NOTE: This test can only be purchased by men with suspect PSA over 4 mg/dL.  Free PSA will not be provided for PSA under 4 ng/mL.

PSA circulates through the body in two ways; bound to other proteins or by itself. Unbound PSA is called free PSA. A free-PSA test will measure the percentage of unbound PSA while a PSA test is used to measure the total of free and bound PSA in the blood. The free PSA is a defective variant of normal PSA that can no longer bind to other proteins and so circulates in the blood in the free form. Although the reason why this is the case is poorly understood - patients with prostate cancer may have lower free PSA levels than those with a benign prostate condition.